These two cancer drugs will soon be PBS-listed

Two more cancer drugs have become available on the PBS from 1st April. They are:

  • Brentuximab vedotin (Adcetris)  – an antibody-drug conjugate for patients with relapsed or refractory Hodgkins lymphoma
  • Vismodegib (Erivedge) – for metastatic or locally advanced basal cell carcinoma.

Three other cancer drugs had PBS listings announced from 1 February:

  • Ceritinib (Zykadia) – for locally advanced (stage IIIb) or metastatic (stage IV) non